HOXB8 - middle region Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-HOXB8 - middle region antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityHOXB8 - middle region
Clonepolyclonal
Host SpeciesRabbit
Reactive Speciesdog, human, mouse, porcine, rat
Isotypen/a
Formataffinity purified
Size0.1 mL
Concentrationn/a
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis is a rabbit polyclonal antibody against HOXB8. It was validated on Western Blot using a cell lysate as a positive control.Target Description: HOXB8 belongs to the Antp homeobox family. It is a nuclear protein with a homeobox DNA-binding domain. This gene is included in a cluster of homeobox B genes located on chromosome 17. The protein functions as a sequence-specific transcription factor that is involved in development. Increased expression of this gene is associated with colorectal cancer. Mice that have had the murine ortholog of this gene knocked out exhibit an excessive pathologic grooming behavior. This behavior is similar to the behavior of humans suffering from the obsessive-compulsive spectrum disorder trichotillomania
ImmunogenImmunogen: The immunogen is a synthetic peptide directed towards the middle region of human HOXB8
Other Names[homeobox protein Hox-B8; Homeobox protein Hox-B8; homeobox protein Hox-B8; homeobox B8; Homeobox protein Hox-2.4; Homeobox protein Hox-2D]
Gene, Accession #[HOXB8], Gene ID: 3218, NCBI: NP_076921, UniProt: P17481
Catalog #MBS3202898
Price$335
Order / More InfoHOXB8 - middle region Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.